Globus Medical GMED Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's cash provided by (used in) financing activity, including discontinued operation?
- Globus Medical (GMED) reported cash provided by (used in) financing activity, including discontinued operation of $18.2M in Q1 2026.
- How has Globus Medical's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Globus Medical's cash provided by (used in) financing activity, including discontinued operation increased by 102.9% year-over-year, from -$635.4M to $18.2M.
- What is the long-term trend for Globus Medical's cash provided by (used in) financing activity, including discontinued operation?
- Over 2 years (2021 to 2025), Globus Medical's cash provided by (used in) financing activity, including discontinued operation has grown at a 254.3% compound annual growth rate (CAGR), from $55.17M to -$692.38M.